From Screening to Follow-Up: What Can You Expect When Taking Part in a Clinical Trial?
Taking part in a clinical trial can feel unfamiliar. Discover what you can typically expect, from initial screening and consent to study visits and final follow-up. We familiarise you with the process.
AI model may predict pancreatic cancer risk up to 5 years before diagnosis
Researchers have developed an artificial intelligence model that could help identify people at increased risk of pancreatic cancer up to five years before diagnosis, potentially helping earlier detection.
Who is behind a clinical trial? Meet the people who make clinical research possible.
Discover the many professionals working behind every clinical trial and their roles. Learn about the people you will meet if you take part and the work that goes on behind the scenes.
New hope for breast cancer patients as life-extending drug now on NHS in England
Following years of campaigning, patients in England with a specific type of incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body.
Could a Common Diabetes Drug Help Slow Ageing?
Through the TAME study, researchers are investigating whether metformin, a common diabetes drug, could help delay age-related diseases and extend the number of years people live in good health.
Helen’s story: Taking part in a clinical trial with COPD
After being diagnosed with COPD five years ago, Helen decided to take part in a clinical trial through the British Research Panel. Seven months in, she shares what the experience has really been like and why she’d encourage others to consider research.
What rights and safeguards protect clinical trial participants?
Clinical trial participants are protected by strict ethical and regulatory safeguards before and throughout a study. Learn how informed consent, ongoing safety monitoring and the right to withdraw help protect participants’ rights.
Personalised Cancer Vaccine Shows Promise in Preventing Melanoma Returning
A personalised cancer vaccine has shown promising results in a Phase 3 clinical trial, helping to prevent melanoma from returning in patients at high risk of their cancer coming back.
British Research Panel Members Contribute to Progressing Type 1 Diabetes Research
Over 1,800 British Research Panel members signed up to the T1DRA study, a type 1 diabetes study led by the University of Bristol. The study aims to find how many adults in the UK are at increased risk of developing type 1 diabetes.
Why Might You Not Be Eligible for a Clinical Trial
Clinical studies often seek participants with specific conditions, treatment histories and health characteristics. Learn why you may not be able to take part, even when the study concerns your condition.